Creative Planning Omeros Corp Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
BUY
$5.67 - $8.54 $63,900 - $96,245
11,270 New
11,270 $72,000
Q3 2020

Nov 05, 2020
SELL
$9.57 - $21.32 $154,794 - $344,851
-16,175 Closed
0 $0
Q2 2020

Jul 23, 2020
BUY
$12.21 - $16.99 $197,496 - $274,813
16,175 New
16,175 $238,000

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email